Albireo to present at upcoming jefferies and william blair virtual investor conferences

Boston, may 26, 2021 (globe newswire) -- albireo pharma, inc. (nasdaq: albo), a rare liver disease company developing novel bile acid modulators, today announced that ron cooper, president and chief executive officer, will present as part of fireside chats at both the 2021 jefferies virtual healthcare conference on wednesday, june 2, at 9:30 a.m. edt and william blair's 41st annual growth stock conference on thursday, june 3, at 12:40 p.m. edt. members of the management team will also host meetings with investors june 1-3.
ALBO Ratings Summary
ALBO Quant Ranking